A Phase III Study of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy in Patients with Cutaneous Melanomas that Have Metastasized to the Sentinel Node
[Protocol 09-112] |
Ariyan, Charlotte |
|
A Phase III Study of Sapacitabine in Elderly Patients Newly Diagnosed with Acute Myeloid Leukemia
[Protocol 12-034] |
Berman, Ellin |
- Geriatrics
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
|
A Phase III Study of Rituximab/Lenalidomide or Rituximab/Chemotherapy Followed by Rituximab Maintenance Therapy in Patients with Previously Untreated Follicular Lymphoma
[Protocol 12-081] |
Palomba, M. Lia |
|
A Phase III Study of Rituximab plus GS-1101 (CAL-101) or Placebo for Previously Treated Chronic Lymphocytic Leukemia
[Protocol 12-160] |
Zelenetz, Andrew |
- Leukemia
- Chronic Lymphocytic Leukemia
|
A Phase III Study of Radiation Therapy with and without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
[Protocol 11-120] |
Kaley, Thomas |
- Brain Tumors, Primary
- Pediatric Brain Tumors
|
A Phase III Study of ProstAtakTM as an Adjuvant to Up-front Radiation Therapy for Localized Prostate Cancer
[Protocol 11-172] |
Zelefsky, Michael |
|
A Phase III Study of Postoperative Radiation Therapy with and without Cetuximab for Locally Advanced Resected Head and Neck Cancer
[Protocol 10-081] |
Lee, Nancy |
|
A Phase III Study of Ponatinib versus Imatinib for Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
[Protocol 12-216] |
Berman, Ellin |
- Leukemia
- Chronic Myelocytic Leukemia
|
A Phase III Study of Pazopanib as Adjuvant Therapy for Patients with Localized or Locally Advanced Renal Cell Carcinoma Following Nephrectomy
[Protocol 10-162] |
Motzer, Robert |
|
A Phase III Study of Paclitaxel plus Carboplatin Versus Ifosfamide plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Persistent or Recurrent Carcinosarcoma of the Uterus
[Protocol 10-007] |
Hensley, Martee |
- Endometrial and other Uterine Cancers
- Sarcomas
|
A Phase III Study of Ofatumumab versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
[Protocol 11-079] |
Matasar, Matthew |
|
A Phase III Study of Nilotinib (Tasigna®) versus Dacarbazine in Patients with Advanced Melanoma with a c-Kit Mutation (TEAM Trial
[Protocol 10-102] |
Carvajal, Richard |
|
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
[Protocol 07-041] |
Eastham, James |
|
A Phase III Study of Multimodality Therapy for Extra-ocular Retinoblastoma
[Protocol 08-072] |
Dunkel, Ira |
|
A Phase III Study of Lenalidomide, Bortezomib, and Dexamethasone Combination Treatment with or without Peripheral Stem Cell Transplantation in the Initial Management of Multiple Myeloma
[Protocol 12-018] |
Hassoun, Hani |
|
A Phase III Study of Lenalidomide Alone and in Combination with Epoetin Alfa in Patients with Myelodysplastic Syndromes and Symptomatic Anemia
[Protocol 10-128] |
Klimek, Virginia |
|
A Phase III Study of KW-0761 versus Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma
[Protocol 13-007] |
Moskowitz, Alison |
|
A Phase III Study of Inotuzumab Ozogamicin with Rituximab versus Standard Therapy for Patients with Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
[Protocol 12-005] |
Hamlin, Paul |
|
A Phase III Study of Ibritumomab Tiuxetan versus Observation in Older Patients with Diffuse Large B-Cell Lymphoma in Remission following R-CHOP
[Protocol 12-061] |
Hamlin, Paul |
|
A Phase III Study of Hormone Therapy with and without Chemotherapy in Patients with HER2-Negative Breast Cancer and 1-3 Positive Lymph Nodes and a Recurrence Score of 25 or Less
[Protocol 12-118] |
Lake, Diana |
|
